We are live on ! Find out more
AVAI

Atlas Venture Associates IX Portfolio holdings

AUM $11.8M
1-Year Est. Return 58.35%
This Fund
S&P 500
This Quarter Est. Return
-49.68%
1 Year Est. Return
-58.35%
3 Year Est. Return
-89.8%
5 Year Est. Return
-87.69%
10 Year Est. Return
–
AUM
$44M
AUM Growth
-$64.7M
Cap. Flow
-$3.07M
Cap. Flow %
-6.98%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
COGT icon
Cogent Biosciences
COGT
+$3.07M

Sector Composition

Rank Sector Weight
1 Communication Services 69.03%
2 Healthcare 30.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIRY
1
Firy Inc
FIRY
$146M
$28.4M 64.55%
1,145,493
– –
SURF
2
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$4.83M 10.98%
2,945,453
– –
COGT icon
3
Cogent Biosciences
COGT
$7.34B
$4.21M 9.57%
466,832
-450,000
-49% -$3.07M
SYBX
4
DELISTED
Synlogic
SYBX
$3.05M 6.93%
176,798
– –
SNAP icon
5
Snap
SNAP
$9.72B
$1.97M 4.48%
150,160
– –
SPRO icon
6
Spero Therapeutics
SPRO
$70.6M
$1.02M 2.32%
1,376,968
– –
NTLA icon
7
Intellia Therapeutics
NTLA
$1.57B
$518K 1.18%
10,000
– –

Similar funds

EEPIS
Evolution Equity Partners II SARL Luxembourg $11.8M AUM 63.6% 1-Year Est. Return
LM
Lockheed Martin Bethesda, Maryland $12.1M AUM 46.13% 1-Year Est. Return
HMP9
Highland Management Partners 9 Cambridge, Massachusetts $12.6M AUM 85.13% 1-Year Est. Return
TCSAM
Tyrus Capital S.A.M. Monaco $10.5M AUM 4.88% 1-Year Est. Return
AEM
ACON Equity Management Washington, District of Columbia $13.8M AUM 62.17% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
AR
Acacia Research New York $14.1M AUM 50.98% 1-Year Est. Return
MM
Malka Meyer $8.77M AUM 64.77% 1-Year Est. Return

Atlas Venture Associates IX's Q2 2022 Portfolio in Review

As of Q2 2022, Atlas Venture Associates IX held 7 positions worth $44M, down 60% from $109M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Atlas Venture Associates IX withdrew a net $3.07M in Q2 2022, reducing 1 holding. Its largest reduction was Cogent Biosciences, cutting an estimated $3.07M.

By sector, the portfolio is most concentrated in Communication Services at 69% of assets, up from 68% a quarter earlier, followed by Healthcare.

  • Atlas Venture Associates IX's biggest Q2 2022 reduction was Cogent Biosciences, cutting an estimated $3.07M.
  • Atlas Venture Associates IX's ten largest holdings make up 100% of its $44M portfolio in Q2 2022.
  • Atlas Venture Associates IX opened 0 new positions and closed 0 in Q2 2022.
  • Atlas Venture Associates IX's portfolio value fell 60% quarter-over-quarter to $44M.

Based on Atlas Venture Associates IX's 13F filing for Q2 2022, filed 11 Aug 2022.